This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Jul 1;14(13):4353.

doi: 10.1158/1078-0432.CCR-08-0350.

Frontline therapy for chronic lymphocytic leukemia: the dilemma continues

PMID: 18594019
DOI: 10.1158/1078-0432.CCR-08-0350

Comment

Frontline therapy for chronic lymphocytic leukemia: the dilemma continues

Chadi Nabhan. Clin Cancer Res. 2008.

. 2008 Jul 1;14(13):4353.

doi: 10.1158/1078-0432.CCR-08-0350.

Author

PMID: 18594019
DOI: 10.1158/1078-0432.CCR-08-0350

No abstract available

PubMed Disclaimer

Comment on

Fludarabine, cyclophosphamide, and mitoxantrone as initial therapy of chronic lymphocytic leukemia: high response rate and disease eradication.
Bosch F, Ferrer A, Villamor N, González M, Briones J, González-Barca E, Abella E, Gardella S, Escoda L, Pérez-Ceballos E, Asensi A, Sayas MJ, Font L, Altés A, Muntañola A, Bertazzoni P, Rozman M, Aymerich M, Giné E, Montserrat E. Bosch F, et al. Clin Cancer Res. 2008 Jan 1;14(1):155-61. doi: 10.1158/1078-0432.CCR-07-1371. Clin Cancer Res. 2008. PMID: 18172266 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems